Spero Therapeutics, Inc. Common Stock(SPRO)
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
Snapshot
$2.14
- 52-Week Range
- $1.80 – $3.22
- YTD
- -8.94%
- IV Rank (30D)
- 50.75
- Straddle Price
- $0.72
- P/C Vol Ratio
- 0.23
- Market Cap
- $0.2B
Fair Value
+50.0% vs price
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.48% |
| Beta vs SPY | 1.00 |
| Cost of Equity (CAPM) | 9.98% (VRP-adj) |
| WACC | 9.99% |
| Volatility Risk Premium | +97.2pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 1.7% |
| Rev. Growth (YoY, DCF input) | -10.0% |
| DCF Horizon | 10 years explicit + fade |
| Free Cash Flow (TTM) | $0.0B |
| Return on Equity (TTM) | 28.8% |
| Book / Price | 33.4% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 100.0% |
| FCF Margin (TTM) | 11.8% |
| Debt / Equity | 0.00 |
| Quality Score | 3/6 — normal (10y DCF) |
| Market-Implied Growth | +3.1% (reverse-DCF on current price) |
| SMA 50 | $2.70 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $2.78 |
| Bollinger Width / SMA20 | 626.2% (drives anchor stability) |
| Net Debt | $-0.1B |
| Market Cap | $0B |
Peers used for multiples: ACRS, ALKS, CCCC, CYRX, IART, OVID
(filtered from 8 ETF-co-members; sector bias active)
Blended Fair Value
$4.25
Current Price
$2.13
Deviation
+50.0%
Forward-Return Rank
LONG
gated
?
| Horizon | Expected α | z Pred | Blended z | Rank % | Active? |
|---|---|---|---|---|---|
| 21d | -1.1% ⚠ | +0.70 | +2.18 | 99.1% | — |
| 42d | -1.7% ⚠ | +0.82 | +2.24 | 99.2% | — |
| 63d | -1.0% ⚠ | +1.12 | +2.39 | 99.4% | — |
Expected α = forward-return point estimate vs SPY (e.g., +7.5% means the predictor expects this stock to outperform SPY by 7.5% over that horizon).
For SHORT direction the model uses a different ranking metric (conviction-weighted deviation, not the LGBM prediction); Expected α is shown for reference.
⚠ flags rows where Expected α disagrees with the FV direction — two independent signals are in conflict; conviction is low even if rank looks extreme.
Forward-Return Rank. A proprietary ensemble of a machine-learning forward-return model and a conviction-weighted fundamental score, ranked cross-sectionally each day across the S&P 500 (and broader universes on the screener). Each stock is scored at three horizons (21/42/63 trading days). "Active" = top/bottom 5% AND all risk filters pass. Backtested mean alpha vs SPY on active picks: 21d LONG +13.4%, 63d +34.9% (S&P 500, walk-forward). Past performance is not indicative of future results.
Value vs momentum conflict ⚠. The "FV direction" (long/short) comes from the fundamentals-based engine — price vs intrinsic value. The "Expected α" comes from a separate machine-learning predictor trained on ~12 features (sector, options-implied move, beta, institutional flow, etc.). Sometimes the two disagree: a stock is overvalued by fundamentals but the predictor expects it to keep outperforming (sector or momentum tailwinds). When all 3 horizons disagree, treat the direction signal as low-conviction — neither model is strongly recommending a position.
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $1.83 | 56% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | |
| Peer EV/EBITDA | n/a | 0% | |
| Peer P/B | $1.82 | 10% | median 2.0× · 6 peers |
| Peer P/S | $9.02 | 34% | median 8.4× · 6 peers |
| Market Anchor (SMA50) | $2.70 | 0% | stability 0% (BB-width) |
| Options Expected (B-L 30d) | n/a | 0% |
As of 2026-06-17 · updated 2026-06-17 18:37:30.801000
Info
- Industry (SIC)
- PHARMACEUTICAL PREPARATIONS (2834)
- Exchange
- XNAS
- Market Cap
- $0.2B
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is al…
Chart
Seasonality
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | -6.45% | 6 |
| Feb | -5.99% | 6 |
| Mar | +0.11% | 6 |
| Apr | +0.50% | 6 |
| May | +48.01% | 6 |
| Jun | -13.51% | 6 |
| Jul | -3.21% | 5 |
| Aug | +10.09% | 5 |
| Sep | +22.37% | 5 |
| Oct | -0.43% | 5 |
| Nov | -4.67% | 5 |
| Dec | +4.82% | 5 |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $2.75
SMA 50: $2.69
SMA 200: $2.40
Current: $2.13
EMA 12: $2.67
EMA 26: $2.69
MACD: -0.0214 | Signal: -0.0466
BULLISH
ADX (14): 19.99
RANGE
+DI: 18.47
−DI: 37.07
Momentum Oscillators
RSI (14): 33.28
NEUTRAL
Stoch %K: 45.72
Stoch %D: 54.43
Williams %R: -83.88
Volume & Volatility
BB Upper: $3.12
BB Lower: $2.39
OVERSOLD
OBV: 203,614,565
Vol SMA 20: 1,335,106
Vol ROC: 1121.81%
ATR: $0.24
True Range: $1.10
HV 20: 110.9%
HV 30: 101.9%
HV 60: 79.3%
Data Summary
Data Points: 500
Last Updated: 2026-06-17T18:35:21.551000
Date Range: 2024-06-18T00:00:00 – 2026-06-16T00:00:00
AI Analysis
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
News
Earnings History
8 of 8 under expected move
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2024-08-05 | Pre-Market | 314.89% | 10.69% | 0.03x | Within |
| 2024-10-29 | After-Close | 610.29% | 24.51% | 0.04x | Within |
| 2025-01-10 | After-Close | 655.61% | 0.00% | 0.00x | Within |
| 2025-03-27 | Pre-Market | 393.84% | 4.75% | 0.01x | Within |
| 2025-05-13 | After-Close | 177.54% | 9.88% | 0.06x | Within |
| 2025-08-12 | Pre-Market | 25.00% | 6.82% | 0.27x | Within |
| 2025-11-13 | Pre-Market | 28.20% | 10.90% | 0.39x | Within |
| 2026-03-26 | After-Close | 23.28% | 5.67% | 0.24x | Within |
Options Activity
- IV Rank (30D)
- 50.75
- IV Rank (7D)
- 100
- Avg IV
- 202.6%
- Straddle (30D)
- $0.72
- Straddle (7D)
- $0.42
- P/C Volume
- 0.23
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
- Beta (1Y vs SPY)
- 1.35
- Correlation (SPY)
- 28.8%
- R²
- 0.08
- Ann. Volatility
- 57.7%
- SPY Volatility
- 12.4%
High volatility - stock moves more than market
Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-03-31
? 13F Guide
Diluted shares outstanding: 57,157,101 (as of 2026-03-31)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
4 filers$194.22K notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | JANE STREET GROUP, LLC Custodian | $88.45K | 45.54% | 2026-03-31 |
| 2 | CITADEL ADVISORS LLC Custodian | $62.48K | 32.17% | 2026-03-31 |
| 3 | GROUP ONE TRADING LLC Custodian | $43.06K | 22.17% | 2026-03-31 |
| 4 | SIMPLEX TRADING, LLC Custodian | $234 | 0.12% | 2026-03-31 |
5 filers$350.30K notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $113.49K | 32.40% | 2026-03-31 |
| 2 | JANE STREET GROUP, LLC Custodian | $90.09K | 25.72% | 2026-03-31 |
| 3 | SIMPLEX TRADING, LLC Custodian | $77.69K | 22.18% | 2026-03-31 |
| 4 | CITADEL ADVISORS LLC Custodian | $52.65K | 15.03% | 2026-03-31 |
| 5 | GROUP ONE TRADING LLC Custodian | $16.38K | 4.68% | 2026-03-31 |
Insider Activity
Latest: 2026-05-06
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-05-06 | Esther Rajavelu | See Remarks | Sell (S) | −25,240 | $2.51 | -$63.4K | EDGAR |
| 2026-02-09 | Timothy Keutzer | Chief Operating Officer | Sell (S) | −18,652 | $2.36 | -$44.0K | EDGAR |
| 2026-02-09 | Esther Rajavelu | See Remarks | Sell (S) | −87,917 | $2.36 | -$207.5K | EDGAR |
| 2026-02-05 | Timothy Keutzer | Chief Operating Officer | Mixed | +21,414 | $2.17 | -$101.2K | EDGAR |
| 2026-02-04 | Esther Rajavelu | See Remarks | Mixed | +230,558 | $2.20 | -$40.6K | EDGAR |
| 2025-11-12 | Esther Rajavelu | See Remarks | Sell (S) | −40,270 | $2.37 | -$95.4K | EDGAR |
| 2025-09-03 | Ankit Mahadevia | Director | Sell (S) | −6,572 | $1.97 | -$12.9K | EDGAR |
| 2025-09-03 | Timothy Keutzer | Chief Operating Officer | Sell (S) | −1,695 | $1.97 | -$3.3K | EDGAR |
| 2025-06-16 | John C Jr Pottage | Director | Award (A) | +20,000 | — | EDGAR | |
| 2025-06-16 | PATRICK V.J.J. VINK | Director | Award (A) | +20,000 | — | EDGAR | |
| 2025-06-16 | Scott Thomas Jackson | Director | Award (A) | +20,000 | — | EDGAR | |
| 2025-06-16 | Milind Deshpande | Director | Award (A) | +20,000 | — | EDGAR | |
| 2025-06-16 | Kathleen Tregoning | Director | Award (A) | +20,000 | — | EDGAR | |
| 2025-06-16 | Cynthia Smith | Director | Award (A) | +20,000 | — | EDGAR | |
| 2025-06-16 | FRANK E THOMAS | Director | Award (A) | +20,000 | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
30 insiders · @ $2.13
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Aquilo Capital Management, LLC | 10%+ Owner | 5,321,231 | $11.33M | $14.85M | 13 | 2022-04-28 |
| 2 | Aquilo Capital, L.P. | 10%+ Owner | 3,985,719 | $8.49M | -$863.5K | 10 | 2022-09-26 |
| 3 | JEAN FRANCOIS FORMELA | Director | 1,979,557 | $4.22M | $6.00M | 6 | 2021-08-18 |
| 4 | GSK plc | 10%+ Owner | 1,934,006 | $4.12M | $7.00M | 2 | 2018-07-17 |
| 5 | Sath Shukla | CEO & President | 1,892,216 | $4.03M | -$305.7K | 11 | 2025-02-05 |
| 6 | Vikas Goyal | Director | 1,425,435 | $3.04M | $6.00M | 1 | 2017-11-07 |
| 7 | Esther Rajavelu | See Remarks | 986,851 | $2.10M | -$476.0K | 9 | 2026-05-06 |
| 8 | Casper Breum | Director | 877,489 | $1.87M | $3.00M | 2 | 2018-06-06 |
| 9 | KAMAL HAMED | Chief Medical Officer | 816,192 | $1.74M | -$88.6K | 5 | 2024-02-05 |
| 10 | Timothy Keutzer | Chief Operating Officer | 742,506 | $1.58M | -$246.4K | 12 | 2026-02-09 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
| P/E Ratio | 7.9 |
| P/B Ratio | 3.2 |
| P/S Ratio | 2.8 |
| EV/EBITDA | 7.9 |
| TTM Revenue | $0.1B |
| TTM Net Income | $0.0B |
| TTM EPS | $0.27 |
| ROE | 28.8% |